Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+327,803
Put/Call ratio
63%
SEC-reported price per share
$48.20
Number of holders
195
Value change
-$49,596,066
Number of buys
108
Open additional details 1 more signal available
Number of sells
97
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
213,001,347

Security key

86366E106

Report period

Q1 2026

Institutions

195

Top holders

10

Ownership snapshot

Top reported holders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 15% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
WELLINGTON MANAGEMENT GROUP LLP 10%
Avoro Capital Advisors LLC 9.4%
JANUS HENDERSON GROUP PLC 7.7%
Deep Track Capital, LP 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
15%
$2,163,883,695
31,112,634 shares
+$776,609,280 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP
13D/G 13F
Company
10%
$1,481,942,431
21,365,952 shares
+$50,941,729 31 Dec 2025
Avoro Capital Advisors LLC
13F 13D/G
Company
9.4%
from 13D/G
$455,938,850
6,555,555 shares
31 Dec 2025
JANUS HENDERSON GROUP PLC
13F 13D/G
Company
7.7%
from 13D/G
$354,005,522
5,090,148 shares
31 Dec 2025
Deep Track Capital, LP
13D/G 13F
Company
6%
$855,579,599
12,335,346 shares
-$21,646,354 31 Dec 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
4.9%
$723,914,898
10,437,066 shares
+$57,243,848 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
195
Shares
66,450,436
Rows available
195
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
197
Q1 2026 holders
195
Holder diff
-2
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .